pI: 6.449 |
Length (AA): 1220 |
MW (Da): 144605 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 11 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
67 | 1064 | 3bta (A) | 196 | 1276 | 19.00 | 0.000013 | 1 | 0.77 | 1.2 |
589 | 887 | 1got (B) | 68 | 340 | 15.00 | 0 | 1 | 0.37 | -0.51 |
398 | 887 | 2ymu (A) | 7 | 495 | 18.00 | 0 | 1 | 0.432239 | 1.09 |
727 | 808 | 3ow8 (A) | 185 | 267 | 32.00 | 0.0041 | 0.63 | 0.509913 | -0.85 |
731 | 804 | 3jro (A) | 8 | 86 | 46.00 | 0.046 | 0.98 | 0.568356 | -0.25 |
731 | 804 | 4l9o (A) | 2019 | 2097 | 43.00 | 0.07 | 0.98 | 0.564356 | -0.51 |
364 | 888 | 2ymu (A) | 33 | 577 | 18.00 | 0 | 1 | 0.483975 | 0.78 |
728 | 809 | 3ow8 (A) | 185 | 267 | 32.00 | 0.0041 | 0.63 | 0.510558 | -0.85 |
732 | 805 | 3jro (A) | 8 | 86 | 46.00 | 0.047 | 0.98 | 0.569006 | -0.25 |
732 | 805 | 4l9o (A) | 2019 | 2097 | 43.00 | 0.07 | 0.98 | 0.565006 | -0.51 |
1035 | 1210 | 4u5a (C) | 49 | 239 | 18.00 | 0.63 | 0.18 | 0.195144 | -0.01 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | intra-erythrocytic - 0 hs, intra-erythrocytic - 8 hs, intra-erythrocytic - 16 hs, intra-erythrocytic - 24 hs, intra-erythrocytic - 32 hs, gametocyte, merozoite, sporozoite, early ring, early trophozoite, late ring, Ring, Sporozoite, Female Gametocyte. | Otto TD PlasmoDB Zanghi G Lasonder E |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | intra-erythrocytic - 48 hs, late trophozoite, Oocyst. | Otto TD PlasmoDB Zanghi G |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | intra-erythrocytic - 40 hs, Male Gametocyte. | Otto TD Lasonder E |
Lasonder E | Integrated transcriptomic and proteomic analyses of P. falciparum gametocytes. Molecular insight into sex-specific processes and translational repression. |
Otto TD | New insights into the blood-stage transcriptome of Plasmodium falciparum using RNA-Seq. |
Zanghi G | A Specific PfEMP1 Is Expressed in P. falciparum Sporozoites and Plays a Role in Hepatocyte Infection. |
PlasmoDB | Data on upregulation of P. falciparum genes in different life cycle stages, combined from several microarray experiments available in PlasmoDB |
Ortholog group members (OG5_128119)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT5G16750 | WD-40 repeat protein TOZ |
Babesia bovis | BBOV_II006870 | WD domain, G-beta repeat containing protein |
Brugia malayi | Bm1_43000 | MGC69179 protein |
Candida albicans | CaO19.4268 | similar to S. cerevisiae YLR222C |
Candida albicans | CaO19.11744 | similar to S. cerevisiae YLR222C |
Caenorhabditis elegans | CELE_Y53C12B.1 | Protein Y53C12B.1 |
Cryptosporidium hominis | Chro.40108 | similar to WD40-repeat protein |
Cryptosporidium hominis | Chro.40109 | similar to transducin beta-like 3; WD-repeat protein SAZD |
Cryptosporidium parvum | cgd4_900 | WD repeat containing protein |
Dictyostelium discoideum | DDB_G0276283 | U3 small nucleolar ribonucleoprotein |
Drosophila melanogaster | Dmel_CG1671 | CG1671 gene product from transcript CG1671-RA |
Echinococcus granulosus | EgrG_001180500 | transducin beta protein 3 |
Entamoeba histolytica | EHI_140750 | WD domain containing protein |
Echinococcus multilocularis | EmuJ_001180500 | transducin beta protein 3 |
Giardia lamblia | GL50803_15487 | WD-40 repeat protein |
Homo sapiens | ENSG00000183751 | transducin (beta)-like 3 |
Leishmania braziliensis | LbrM.25.0380 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_250440.1 | WD domain, G-beta repeat/Utp13 specific WD40 associated domain containing protein, putative |
Leishmania infantum | LinJ.25.0440 | hypothetical protein, conserved |
Leishmania major | LmjF.25.0430 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.25.0430 | hypothetical protein, conserved |
Loa Loa (eye worm) | LOAG_05625 | hypothetical protein |
Mus musculus | 213773 | transducin (beta)-like 3 |
Oryza sativa | 4336833 | Os04g0592700 |
Onchocerca volvulus | OVOC9954 |
|
Plasmodium berghei | PBANKA_1211500 | U3 small nucleolar RNA-associated protein 13, putative |
Plasmodium falciparum | PF3D7_1013100 | U3 small nucleolar RNA-associated protein 13, putative |
Plasmodium knowlesi | PKNH_0812900 | U3 small nucleolar RNA-associated protein 13, putative |
Plasmodium vivax | PVX_094875 | hypothetical protein, conserved |
Plasmodium yoelii | PY01359 | hypothetical protein |
Saccharomyces cerevisiae | YLR222C | Utp13p |
Schistosoma japonicum | Sjp_0046360 | U3 small nucleolar RNA-associated protein 13, putative |
Schistosoma mansoni | Smp_050470 | hypothetical protein |
Schmidtea mediterranea | mk4.031167.01 | |
Schmidtea mediterranea | mk4.013254.00 | |
Trypanosoma brucei gambiense | Tbg972.11.370 | hypothetical protein, conserved,predicted WD40 repeat protein |
Trypanosoma brucei | Tb927.11.460 | predicted WD40 repeat protein |
Trypanosoma brucei | Tb11.v5.0726 | WD domain, G-beta repeat/Utp13 specific WD40 associated domain containing protein, putative |
Trypanosoma congolense | TcIL3000.11.400 | predicted WD40 repeat protein |
Trypanosoma cruzi | TcCLB.507093.170 | hypothetical protein, conserved |
Theileria parva | TP02_0662 | hypothetical protein |
Trichomonas vaginalis | TVAG_288620 | WD-repeat protein, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb11.03.0680 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb11.03.0680 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb11.03.0680 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb11.03.0680 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_Y53C12B.1 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_Y53C12B.1 | Caenorhabditis elegans | slow growth | wormbase |
YLR222C | Saccharomyces cerevisiae | inviable | yeastgenome |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.